Jazz Pharmaceuticals plc Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2011 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Jazz Pharmaceuticals plc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2011 to Q1 2024.
  • Jazz Pharmaceuticals plc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$56.6M, a 89.8% decline year-over-year.
  • Jazz Pharmaceuticals plc annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$305M, a 42.4% increase from 2022.
  • Jazz Pharmaceuticals plc annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$529M, a 113% decline from 2021.
  • Jazz Pharmaceuticals plc annual Net Cash Provided by (Used in) Financing Activities for 2021 was $3.97B, a 652% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$56.6M -$26.8M -89.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q1 2023 -$29.8M +$241M +89% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q1 2022 -$271M -$289M -1582% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q1 2021 $18.3M +$166M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q1 2020 -$148M -$17.3M -13.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q1 2019 -$130M -$82.8M -174% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q1 2018 -$47.6M +$134M +73.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q1 2017 -$182M -$29.2M -19.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q1 2016 -$152M -$149M -4575% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q1 2015 -$3.26M -$501M -101% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q1 2014 $498M +$495M +15785% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q1 2013 $3.13M +$21.4M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q1 2012 -$18.2M -$15.2M -510% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-07
Q1 2011 -$2.99M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.